
January 12th, 2023 – Pittsburgh, PA Last week the Food and Drug Administration (FDA) granted accelerated approval to lecanemab, brand name LEQEMBI, for…
January 12th, 2023 – Pittsburgh, PA Last week the Food and Drug Administration (FDA) granted accelerated approval to lecanemab, brand name LEQEMBI, for…